WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002026975) NOVEL POLYPEPTIDE- HUMAN RHOMBUS RELATED PROTEIN 48-35.53 AND POLYNUCLEOTIDE ENCODING IT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/026975    International Application No.:    PCT/CN2001/001363
Publication Date: 04.04.2002 International Filing Date: 10.09.2001
Chapter 2 Demand Filed:    01.04.2002    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: SHANGHAI BIOWINDOW GENE DEVELOPMENT INC. [CN/CN]; 12th Floor, 3rd Building, No. 1111 Zhongshan Bei Er Road, Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI ZHI XIN PATENT AGENT LTD.; 10, Italy Building, 446 Zhao Jia Bang Road, Shanghai 200031 (CN)
Priority Data:
00 1 25187.2 12.09.2000 CN
Title (EN) NOVEL POLYPEPTIDE- HUMAN RHOMBUS RELATED PROTEIN 48-35.53 AND POLYNUCLEOTIDE ENCODING IT
(FR) NOUVEAU POLYPEPTIDE, PROTEINE HUMAINE 48-35.53 ASSOCIEE AU RHOMBOIDE, ET POLYNUCLEOTIDE CODANT CE POLYPEPTIDE
Abstract: front page image
(EN)The invention concerns human rhombus related protein 48-35.53 and polynucleotide encoding it. The invention also concerns the process of producing the polypeptide by recombinant DNA technique. The methods for treating many diseases e.g. tumor, disorder of embryo development, etc. utilizing the polypeptide are disclosed. The invention discloses the antagonist against the polypeptide and therapeutics thereof. The invention also discloses the uses of the polynucleotide, which encodes human rhombus related protein 48-35.53.
(FR)L'invention concerne un nouveau polypeptide, une protéine humaine 48-35.53 associée au rhomboïde, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de malformations apparaissant lors du développement de l'embryon et de tumeurs. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant la protéine humaine 48-35.53 associée au rhomboïde.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)